POTSOrthostatic TestingLab Interpretation
Clinicians diagnose POTS from a sustained heart-rate rise during upright testing, chronic posture-related symptoms and exclusion of other causes. Bloodwork helps identify alternative explanations; it cannot confirm POTS.
Medically reviewed by Thomas Klein, MD
Key takeaways
- Adult threshold: A sustained heart-rate rise of at least 30 beats/min within 10 minutes upright supports POTS in adults aged 20 years and older, when all other criteria are met.
- Adolescent threshold: People aged 12–19 years generally need a sustained rise of at least 40 beats/min; adult thresholds should not be applied automatically to younger children.
- Symptom duration: Contemporary Canadian criteria require frequent orthostatic symptoms for at least 3 months; some older definitions required 6 months.
- Blood pressure: Sustained orthostatic hypotension—a fall of at least 20 mmHg systolic or 10 mmHg diastolic—points toward a different explanation for the upright tachycardia.
- Standing test: Clinicians usually record a lying baseline after 5–10 minutes of rest, then repeat heart rate and blood pressure through 10 minutes of standing.
- Tilt-table testing: A monitored head-up tilt can support the diagnosis when standing results are unclear, but it is not required for every patient.
- Bloodwork: Hemoglobin, ferritin, electrolytes, kidney function and thyroid testing help investigate mimics; no routine blood result establishes a POTS diagnosis.
- Safety: Chest pain, severe breathlessness, exertional fainting or new neurological symptoms need prompt assessment rather than a home standing experiment.
How is POTS diagnosed—and what actually confirms it?
POTS diagnosis requires a sustained heart-rate rise within 10 minutes upright—at least 30 beats/min in adults or 40 beats/min at ages 12–19—plus frequent posture-related symptoms for at least 3 months, without sustained orthostatic hypotension or another explanation. A standing test or tilt-table test documents the pattern; bloodwork excludes mimics.

The diagnosis is a combination, not a single positive test. A heart-rate rise of 35 beats/min in an otherwise well adult does not establish POTS, because symptoms must worsen upright and improve with recumbence; dehydration, anemia, medication effects and other causes must also be considered.
Repeated measurements matter more than the highest number. The CMAJ review by Raj et al. (2022), drawing on Canadian guidance, specifies that the qualifying increase should appear in at least 2 upright readings taken at least 1 minute apart, reducing reliance on a brief movement-related spike.
A routine assessment includes history, examination, orthostatic vital signs and a 12-lead ECG. Clinicians ask whether episodes build gradually after standing or switch on abruptly, because the first pattern fits compensatory sinus tachycardia while the second can indicate an arrhythmia requiring a different investigation.
Kantesti is an AI blood test analyzer that helps explain laboratory findings relevant to suspected POTS, but it cannot measure an upright heart-rate response or make the diagnosis. Information about our organization explains the service behind our educational content; the 10-minute physiological assessment remains a clinical task.
Which heart-rate criteria apply at different ages?
Adults aged 20 years and older generally need a sustained heart-rate increase of at least 30 beats/min within 10 minutes of standing or head-up tilt. Adolescents aged 12–19 years generally need at least 40 beats/min, because healthy adolescents can have larger upright increases than adults.

The age boundary is easy to miss: an 18-year-old generally falls under the 40-beats/min criterion, not the adult 30-beats/min criterion. The 2015 Heart Rhythm Society consensus uses the higher threshold at ages 12–19, reflecting the need to avoid classifying normal youthful responses as a syndrome (Sheldon et al., 2015).
An upright heart rate above 120 beats/min is not required by contemporary diagnostic criteria. For example, an adult whose rate rises from 72 to 106 beats/min may meet the heart-rate component, while someone rising from 102 to 125 beats/min does not meet the increase threshold despite a higher final pulse.
A low resting pulse creates another interpretive problem. Canadian guidance uses a minimum supine heart rate of 60 beats/min when applying its criteria, aiming to avoid labeling a rise from an unusually low athletic baseline to a normal standing rate as POTS; this convention is not identical across all definitions.
Children younger than 12 years need pediatric interpretation rather than a simple adult cutoff. Age-dependent reference values also affect their laboratory reports, which is why our guide to children's lab interpretation separates educational assistance from assessment by a pediatric clinician.
How long must symptoms last before POTS is diagnosed?
Contemporary Canadian POTS criteria require symptoms for at least 3 months, alongside qualifying upright measurements. The symptoms must be frequent, worse while upright and improve after lying down; a fast pulse during a few days of fever or gastrointestinal illness does not establish a chronic autonomic syndrome.

Older publications and some clinical services use a 6-month duration requirement, so apparent disagreement between assessments may reflect different definitions rather than a measurement error. Raj et al. (2022) describes the 3-month criterion; a referral letter should identify the framework used rather than simply saying the test was positive.
Typical symptoms include lightheadedness, palpitations, blurred vision, weakness and fatigue during upright activity. A hypothetical person with 4 months of symptoms while showering or queuing, relieved by lying down, has a more characteristic history than someone with equally severe fatigue that never changes with posture.
Fainting is not necessary for POTS diagnosis, and recurrent fainting does not automatically mean POTS. Documenting whether a 2-minute episode follows standing, exertion, a painful procedure or no recognizable trigger helps distinguish orthostatic intolerance from vasovagal syncope, arrhythmias and other causes of transient loss of consciousness.
Kantesti's educational approach separates symptom overlap from diagnostic proof: 3 months of fatigue plus normal bloodwork is insufficient without the orthostatic pattern. Post-exertional symptom worsening may warrant assessment for ME/CFS diagnostic criteria, which can coexist with POTS but uses a different diagnostic framework.
How does a clinician perform the POTS standing test?
A POTS standing test measures heart rate and blood pressure after 5–10 minutes lying quietly, then during up to 10 minutes of standing. A commonly described schedule records measurements at 1, 3, 5, 8 and 10 minutes, while documenting symptoms and whether the person can safely remain upright.

The lying baseline matters. Comparing a seated pulse with a standing pulse is not equivalent to the standard supine-to-standing assessment, because sitting already imposes some orthostatic stress; using a seated baseline can underestimate the change over the subsequent 10 minutes and obscure an otherwise qualifying pattern.
During testing, the patient usually stands quietly with supervision rather than marching, talking continuously or repeatedly contracting the calves. The leg-muscle pump returns fluid toward the heart, so movement during minutes 3–10 can alter the result; locking the knees or deliberately provoking symptoms is not a useful substitute.
Heart rate and blood pressure should be captured together, with the cuff arm supported near heart level. A cuff reading taken while the arm hangs well below the heart can distort pressure interpretation, while a wrist wearable may show movement artifacts during the first 1 minute after standing.
Preparation should be documented, not improvised. A practical record includes medication timing, recent illness, fluid intake and time of day alongside the 5–10-minute baseline; our baseline testing preparation guide explains why consistent conditions also make accompanying laboratory results more interpretable.
What do orthostatic vital signs reveal about blood pressure?
Orthostatic vital signs assess blood pressure as well as pulse. A sustained fall of at least 20 mmHg systolic or 10 mmHg diastolic within 3 minutes upright meets conventional criteria for classical orthostatic hypotension; that finding can explain compensatory tachycardia and argues against diagnosing POTS from the pulse increase alone.

A hypothetical change from 118/76 to 94/64 mmHg is a fall of 24/12 mmHg. Even if heart rate simultaneously rises by 40 beats/min, the pressure drop changes the interpretation: clinicians should investigate volume depletion, medication effects or impaired pressure regulation instead of treating the pulse threshold as confirmation.
A brief pressure dip immediately after standing is different from sustained orthostatic hypotension. Initial orthostatic hypotension often occurs within roughly 15 seconds and can resolve before an intermittent cuff completes its first measurement; such a transient response does not necessarily exclude POTS when the later pattern meets all criteria.
Symptoms in the first 10–20 seconds can therefore be missed by a normal reading at 1 minute. Continuous beat-to-beat pressure monitoring may clarify that early pattern; clinicians may also assess later falls occurring beyond 3 minutes when the history suggests delayed orthostatic hypotension rather than isolated postural tachycardia.
Normal sodium or potassium does not prove adequate circulating volume. The usual sodium reference interval is approximately 135–145 mmol/L, but dehydration can exist within that interval; our electrolyte result guide explains why concentration, fluid losses and kidney function need to be read together.
How should you calculate and interpret the heart-rate rise?
Calculate the orthostatic heart-rate increase by subtracting the stable lying baseline from each upright reading. Clinicians then look for a sustained increase of at least 30 beats/min in adults or 40 beats/min at ages 12–19, rather than accepting the largest isolated value from a watch or monitor.

Consider a clearly hypothetical 28-year-old with a resting rate of 68 beats/min and standing readings of 92, 101, 104, 103 and 102. The increases are 24, 33, 36, 35 and 34 beats/min; this satisfies the heart-rate component, but symptoms, pressure and exclusions still determine whether POTS is diagnosed.
Now consider a hypothetical 16-year-old whose rate rises from 70 to 106 beats/min and remains there. The 36-beats/min increase exceeds the adult threshold but not the adolescent threshold of 40; the person may still have clinically significant orthostatic intolerance and deserves assessment rather than dismissal.
An isolated peak is less convincing. If an adult goes from 75 to 112 beats/min immediately after standing, then settles to 94–98 throughout minutes 3–10, the brief 37-beats/min spike does not demonstrate a sustained qualifying response; movement artifact or normal early adjustment may explain the peak.
Symptoms do not map neatly onto the size of the rise: a 45-beats/min increase is not automatically more disabling than a 32-beats/min increase. Recording the rhythm and trigger is often more useful for next steps, particularly when reviewing tests for palpitations alongside orthostatic measurements.
What can distort the result—and when should testing be repeated?
Hydration, medication, recent illness and time of day can change upright heart-rate measurements. Orthostatic tachycardia is often greater in the morning, so a negative afternoon assessment may warrant a repeat morning test when the history strongly suggests POTS; repeating testing is not the same as changing conditions to force a positive result.

Acute fever, vomiting, diarrhea or inadequate fluid intake can produce a qualifying rise without establishing POTS. A single 10-minute assessment during such an episode should be interpreted as an acute physiological response until the temporary explanation has resolved and the chronic symptom history can be assessed properly.
Beta-blockers and ivabradine can blunt the pulse increase, while stimulants, some decongestants and norepinephrine-reuptake inhibitors can increase it. Record the exact dose and last administration time—for example, a prescribed morning dose taken 2 hours before testing—and follow the testing service's instructions rather than stopping treatment independently.
Nicotine and caffeine can influence sympathetic activity, but abstinence instructions vary between services and test types. Mention vaping, smoking and nicotine replacement used within the preceding hours; nicotine exposure testing describes exposure assessment, not a test that confirms or excludes POTS.
Poor sleep and a large meal can change symptoms and physiological responses even when the equipment is accurate. A repeat assessment after a 5–10-minute rest should record those circumstances; our poor-sleep testing guide explains why the same context can also complicate accompanying laboratory interpretation.
When is a POTS tilt table test useful?
A POTS tilt table test is useful when standing measurements are inconclusive, safe standing is difficult or the clinician needs more detailed heart-rate and pressure monitoring. A passive head-up tilt, often around 60–70 degrees, can document the response over at least 10 minutes; many straightforward cases do not require it.

Passive tilt differs from active standing because the table supports the person and reduces use of the leg-muscle pump. Heart rate can therefore rise more on tilt than during standing, meaning the two tests are not interchangeable simply because both expose the circulation to gravity for 10 minutes.
Plash et al. (2013) compared 15 people with POTS and 15 controls. Using a 30-beats/min threshold at 10 minutes, specificity was 40% for tilt versus 67% for standing; this small study illustrates why a positive tilt threshold without the appropriate clinical history can misclassify healthy responses.
Longer syncope protocols may continue beyond the initial 10 minutes and sometimes use medication provocation. A later vasovagal fall in pressure or a medication-induced response should not be treated as identical to an unprovoked POTS-pattern response; ask which portion of the protocol supports the proposed diagnosis.
The report should state the tilt angle, baseline rest, duration, medications and monitoring method. The same transparency principle informs our validation and clinical standards: documented methods are necessary for interpretation, but an AI benchmark does not validate a patient's tilt result or replace specialist judgment.
Which blood tests help exclude POTS mimics?
Bloodwork does not confirm POTS. Common investigations include hemoglobin, ferritin, electrolytes, kidney function and thyroid testing; a morning cortisol may be included in a core workup or ordered according to clinical suspicion and local practice. These tests look for alternative explanations for tachycardia, weakness and orthostatic symptoms.

Hemoglobin assesses anemia, while ferritin helps assess iron stores; the two answer different questions. Ferritin of 10 ng/mL can indicate depleted stores even when hemoglobin remains within the local reference interval, so a normal CBC does not make low iron-store symptoms irrelevant.
A suppressed TSH with elevated free T4 suggests thyrotoxicosis, a potential explanation for tachycardia that must be addressed before attributing the pattern to POTS. Free T4 ranges are assay-dependent—often approximately 10–22 pmol/L—so the laboratory's own interval matters when reviewing thyroxine and TSH results.
Morning cortisol needs both sampling time and assay context. A markedly low result, such as below approximately 3 µg/dL or 83 nmol/L, raises concern for adrenal insufficiency but requires clinician-led interpretation; intermediate values may need stimulation testing, as explained in our cortisol timing guide.
Kantesti is an AI blood test interpretation platform that helps explain hemoglobin, ferritin and renal results in context, rather than converting normal values into a POTS label. A BUN/creatinine ratio above 20 may occur with volume depletion when both are expressed in mg/dL, but our kidney ratio interpretation explains its limitations.
How do anemia and iron deficiency change the assessment?
Anemia can cause compensatory tachycardia and must be evaluated before a pulse rise is attributed to POTS. Iron deficiency without anemia may contribute to fatigue and reduced exercise tolerance, but a low ferritin result neither confirms POTS nor proves that iron deficiency explains the entire orthostatic symptom pattern.

For example, a hypothetical adult with hemoglobin of 9.2 g/dL, ferritin of 6 ng/mL and a 38-beats/min upright rise needs assessment of the anemia and its cause. The qualifying pulse change cannot be interpreted in isolation; reduced oxygen-carrying capacity can drive tachycardia before any autonomic diagnosis is established.
Ferritin below approximately 15 ng/mL strongly supports depleted iron stores in otherwise healthy adults, but inflammation can raise ferritin and obscure deficiency. A value of 45 ng/mL during an inflammatory illness is therefore not equivalent to the same value when well; complete iron-study interpretation adds transferrin saturation and clinical context.
The source of deficiency matters as much as replacement. Heavy periods, dietary restriction, gastrointestinal losses and malabsorption call for different investigations; prolonged menstrual flow beyond 7 days is one reason to review heavy menstrual bleeding rather than assuming every symptom belongs to an autonomic condition.
Kantesti AI can help explain why hemoglobin of 9.2 g/dL and ferritin of 6 ng/mL warrant clinical review, but it cannot decide whether anemia fully accounts for a standing-test result. Persistent posture-related symptoms after correction may justify reassessment; an abnormal laboratory result and genuine POTS can coexist.
Why are ECG and rhythm monitoring part of the workup?
A 12-lead ECG helps check that the tachycardia is sinus rhythm and looks for cardiac clues that a pulse monitor cannot identify. A Holter or longer event monitor is selected when symptoms suggest an intermittent arrhythmia, persist independently of posture or remain unexplained after the initial orthostatic assessment.

POTS-related sinus tachycardia usually builds with upright stress and decreases after lying down. An episode that abruptly switches from 80 to 180 beats/min and stops just as suddenly raises a different question, particularly if it occurs while resting; a wearable heart-rate number alone cannot identify the rhythm.
Inappropriate sinus tachycardia can overlap symptomatically with POTS but is less posture-dependent. The 2015 Heart Rhythm Society definition includes a resting sinus rate above 100 beats/min and a mean 24-hour rate above 90 beats/min, with distressing symptoms and no primary cause (Sheldon et al., 2015).
Monitor duration should match episode frequency. Daily events may be captured on a 24–48-hour Holter, whereas less frequent episodes may need a longer monitor; a normal short recording does not exclude an arrhythmia that simply did not occur during the recording period.
Echocardiography and troponin are not routine confirmation tests for uncomplicated POTS. New chest pain, exertional fainting, an abnormal ECG or concerning examination findings may justify a separate cardiac pathway; our troponin testing limits guide explains why 1 normal biomarker cannot settle every cardiac concern.
Do autonomic tests or norepinephrine levels confirm POTS?
Additional autonomic tests and catecholamine measurements are not required for every POTS diagnosis. Specialists may use them to investigate particular mechanisms or a broader autonomic disorder; an upright norepinephrine concentration of at least 600 pg/mL is often used as a hyperadrenergic feature, not as a standalone diagnostic test.

An elevated upright norepinephrine result can reflect compensation for reduced central volume, not simply primary sympathetic overactivity. Values at or above 600 pg/mL therefore need to be interpreted alongside blood pressure, symptoms, medications and the collection protocol; proposed POTS subtypes are not always mutually exclusive.
Catecholamine collection is sensitive to posture and handling. Specialist protocols may obtain samples after at least 10 minutes in specified positions, with their own rest and transport requirements; comparing a seated sample from one laboratory with a prolonged-upright sample from another can create a misleading apparent trend.
Sweat testing, Valsalva testing and heart-rate responses to deep breathing assess different autonomic functions. These investigations may help when there are additional neurological or autonomic features, but a normal result on 1 of them does not erase a documented orthostatic tachycardia pattern or independently rule out POTS.
Kantesti does not treat a norepinephrine value of 600 pg/mL as a positive POTS screen. Episodic headache, sweating and marked hypertension may instead prompt clinician-directed metanephrine testing; our pheochromocytoma testing clues guide explains why that investigation answers a different question.
What if bloodwork is normal or the standing test is negative?
Normal bloodwork does not rule out POTS, because routine laboratory tests do not measure the upright cardiovascular response. A single negative 10-minute standing test also may not settle a strongly suggestive history; clinicians should review test conditions, consider repeat assessment and investigate other explanations rather than automatically confirming or dismissing the syndrome.

Someone with frequent orthostatic symptoms may not meet the heart-rate threshold on a particular day. A hypothetical adult with an increase of 26 beats/min still deserves a symptom-focused assessment, but that result does not satisfy the 30-beats/min component and should not be rounded upward to secure a label.
A repeat morning assessment may be reasonable when the first test followed substantial fluid intake, rate-lowering medication or an abbreviated baseline rest. If repeated, well-performed 10-minute assessments remain below threshold, clinicians should broaden the differential rather than assuming an unrecorded POTS response must exist.
Persistent fatigue, tingling or cognitive symptoms can justify targeted investigations even after a basic panel is normal. A borderline vitamin B12 result around 200–300 pg/mL may need contextual follow-up rather than dismissal, as described in our borderline B12 assessment; exact laboratory thresholds differ.
Clinical features should determine additional testing, not an indiscriminate autoimmune or hormone panel. At least 3 months of symptoms establishes chronicity under contemporary criteria, but it does not identify the cause; sleep disorders, vasovagal susceptibility, medication effects and overlapping post-viral conditions may require separate assessment.
What should you bring next—and what can AI explain?
Bring dated symptoms, medication details, orthostatic measurements and existing laboratory reports to the clinician assessing suspected POTS. A useful record includes the lying baseline, timed readings through 10 minutes, accompanying blood pressure and symptom changes; AI can explain laboratory context, but diagnosis requires clinical assessment of the whole pattern.

A home log should support the consultation, not create a fainting risk. If a clinician recommends home measurements, have assistance, stop when presyncope develops and do not insist on completing 10 minutes; chest pain, severe breathlessness, exertional fainting or new neurological symptoms warrant prompt medical assessment.
Ask 3 practical questions: did my measurements meet the age-appropriate threshold, was sustained orthostatic hypotension absent, and were plausible alternative causes evaluated? A referral report that answers those questions is more useful than a list of pulse peaks without baseline conditions, symptom duration or rhythm information.
Kantesti is an AI lab test interpretation service that helps organize the laboratory part of this discussion while leaving the 10-minute orthostatic assessment to clinicians. Our responsible AI principles describe that boundary; review privacy and your data before sharing reports that contain identifying information.
The 2 Zenodo publications listed below provide supplementary education on kidney ratios and urinalysis, not validation of POTS diagnostic criteria or an AI diagnostic claim. Neither publication establishes a POTS biomarker; the clinical recommendations in this article instead draw on the CMAJ review, Heart Rhythm Society consensus and comparative standing-versus-tilt study listed separately.
Frequently asked questions
How is POTS diagnosed?
POTS is diagnosed when chronic posture-related symptoms occur with a sustained heart-rate rise within 10 minutes upright, without sustained orthostatic hypotension or another explanation. The usual increase threshold is at least 30 beats/min in adults aged 20 years and older and 40 beats/min at ages 12–19. Contemporary Canadian criteria require symptoms for at least 3 months, although some older definitions use 6 months. A clinician combines standing or tilt measurements with history, examination, ECG and selected investigations.
Can a standing test confirm POTS without a tilt table test?
A properly performed standing test can provide the orthostatic measurements needed for POTS diagnosis without a tilt-table test. Clinicians generally obtain a baseline after 5–10 minutes lying quietly and repeat heart rate and blood pressure during 10 minutes of standing. A sustained qualifying increase must occur alongside chronic orthostatic symptoms and exclusion of alternative causes. Tilt testing is useful when results are unclear, standing is unsafe or more detailed monitoring is needed.
Does your heart rate have to exceed 120 to have POTS?
An upright heart rate above 120 beats/min is not required by contemporary POTS criteria. An adult whose rate rises from 72 to 106 beats/min has a 34-beats/min increase and may meet the heart-rate component if it is sustained. A person rising from 102 to 125 beats/min has only a 23-beats/min increase and does not meet that component. Symptoms, blood pressure and alternative explanations still determine the final diagnosis.
What blood tests confirm POTS?
No routine blood test confirms POTS. Hemoglobin, ferritin, electrolytes, kidney function and thyroid tests help identify mimics; morning cortisol may also be appropriate according to the assessment and local protocol. For example, hemoglobin of 9.2 g/dL with ferritin of 6 ng/mL suggests anemia with depleted iron stores, which can contribute to tachycardia and needs investigation. Normal results do not exclude POTS because they do not measure the upright cardiovascular response.
Can a smartwatch diagnose POTS at home?
A smartwatch cannot independently diagnose POTS, although its recordings may help document symptoms for a consultation. Wearables do not reliably provide the simultaneous blood-pressure assessment needed to investigate a sustained fall of at least 20 mmHg systolic or 10 mmHg diastolic. Movement artifacts can also create brief pulse peaks that differ from sustained changes over 10 minutes. Anyone prone to fainting should avoid an unsupervised standing experiment and discuss safe assessment with a clinician.
Can you have POTS with a normal tilt-table test?
A normal tilt-table result does not automatically explain away persistent orthostatic symptoms, but it does not provide confirmation of POTS either. Medication, hydration, time of day and the protocol can affect whether a qualifying rise appears during the first 10 minutes. A clinician may review a previous well-documented standing test, repeat assessment when appropriate or investigate other causes. Repeated tests below the age-specific threshold should prompt reconsideration rather than an assumption that POTS must be present.
Is a 30-beats-per-minute rise enough to diagnose POTS in a teenager?
A 30-beats/min increase generally does not meet the POTS heart-rate criterion for an adolescent aged 12–19 years. The usual adolescent threshold is a sustained rise of at least 40 beats/min within 10 minutes upright. A teenager with a smaller rise may still have significant orthostatic intolerance or another treatable condition. Children younger than 12 years require pediatric interpretation rather than automatic application of adult criteria.
Get your blood test results explained
Upload your lab report and Kantesti's AI explains each biomarker in plain language within seconds. Used by more than 2 million people worldwide.
References
- Klein, T., Mitchell, S., & Weber, H. (2026). BUN/Creatinine Ratio Explained: Kidney Function Test Guide. Kantesti AI Medical Research. DOI
- Klein, T., Mitchell, S., & Weber, H. (2026). Urobilinogen in Urine Test: Complete Urinalysis Guide 2026. Kantesti AI Medical Research. DOI
- Raj SR et al. (2022). Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ. DOI PubMed
- Sheldon RS et al. (2015). 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope. Heart Rhythm. DOI PubMed
- Plash WB et al. (2013). Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics. Clinical Science. DOI PubMed
- 2M+Tests analysed
- 127+Countries
- 100+Languages
About the medical team

Thomas Klein, MD
Lead Author · Medical Reviewer
Chief Medical Officer, Kantesti AI
Dr. Thomas Klein is a board-certified clinical hematologist and internist with over 15 years of experience in laboratory medicine and AI-assisted clinical analysis.

Sarah Mitchell, MD, PhD
Medical Advisor
Chief Medical Advisor - Clinical Pathology & Internal Medicine
Dr. Sarah Mitchell is a board-certified clinical pathologist with over 18 years of experience in laboratory medicine and diagnostic analysis. She holds specialty certifications in clinical chemistry and has published extensively on biomarker panels and laboratory analysis in clinical practice.

Prof. Dr. Hans Weber, PhD
Contributing Expert
Professor of Laboratory Medicine & Clinical Biochemistry
Prof. Dr. Hans Weber brings 30+ years of expertise in clinical biochemistry, laboratory medicine, and biomarker research. Former President of the German Society for Clinical Chemistry, he specializes in diagnostic panel analysis, biomarker standardization, and AI-assisted laboratory medicine.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Medically reviewed by Dr. Thomas Klein, with contributions from Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.
Continue reading
More medical guides from the Kantesti medical team:

Gentamicin Levels: Peak, Trough and Kidney Safety Guide
Understand gentamicin levels, peak and trough timing, once-daily protocols, and kidney or hearing warning signs. Find questions to ask your…
Read article →Voriconazole Trough: Timing, Targets and Dose Safety
Understand your voriconazole trough, treatment and prevention targets, low levels and toxicity signs. See what to discuss with your antifungal…
Read article →
Urine Cystine Test: High Levels, Crystals and Diagnosis
High urine cystine may signal cystinuria, but units and collection quality matter. Understand crystals, stone analysis and family testing, then…
Read article →
Lacosamide Level: Vimpat Ranges and Monitoring Guide
Understand your lacosamide level, why Vimpat ranges differ, and how trough timing, kidney function and side effects change the meaning.…
Read article →
Methotrexate Levels: Delayed Clearance and Rescue Care
Understand methotrexate levels after high-dose treatment, delayed kidney clearance, and time-based leucovorin rescue. Learn what to ask your oncology team.
Read article →
Galactomannan Test Positive: Serum, BAL and False Alarms
A galactomannan test positive may reflect Aspergillus or a false result. Compare serum, BAL, immune risk and antifungal use, and…
Read article →Discover all our health guides and AI-powered blood test analysis tools at kantesti.net
Medical disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
Published · Contact the editorial team
Published by Kantesti Ltd, registered in England & Wales, company no. 17090423, London, United Kingdom.